OncLive SOSS

Integrating Molecular Testing into Decision Making in NSCLC - Episode 6

Using Liquid Biopsy for Molecular Testing in NSCLC

October 26, 2022

Benjamin Levy, MD, Bhuvana Ramkumar, MD, Neil Morganstein, MD

Bhuvana Ramkumar, MD, highlights the strengths of liquid biopsy for molecular testing in NSCLC.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Challenges With and Strategies for Tissue Procurement in NSCLC

EP. 2: Enhancing Communication Among the Multidisciplinary Care Team

EP. 3: Best Practices for Accurate Tissue Genotyping in NSCLC

EP. 4: Average Turnaround Time for NSCLC Molecular Testing

EP. 5: Types of Tissue Next-Generation Sequencing Platforms in NSCLC

EP. 6: Using Liquid Biopsy for Molecular Testing in NSCLC

EP. 7: Integrating Molecular Testing Results into Electronic Medical Records

EP. 8: Receiving Molecular Testing Results for NSCLC

EP. 9: Financial Considerations with Molecular Testing for Patients With NSCLC

EP. 10: The Future of Molecular Testing in NSCLC

x